11β-hydroxylase deficiency natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
 
(4 intermediate revisions by one other user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{MJ}}
{{CMG}}; {{AE}} {{MJ}}
==Overview==
==Overview==
If left untreated, patients with congenital adrenal hyperplasia due to 11β-hydroxylase deficiency may progress to develop [[malignant hypertension]]. Common complications of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency include muscle weakness, metabolic alkalosis, and azoospermia. Prognosis is generally good with treatment.
If left untreated, patients with 11β-hydroxylase deficiency may progress to develop [[malignant hypertension]]. Common [[complications]] of 11β-hydroxylase deficiency include [[muscle weakness]], [[metabolic alkalosis]], [[menstrual irregularities]] in women, [[acne]], [[hirsutism]], and [[infertility]]. Prognosis is generally good with treatment.
==Natural History==
==Natural History==
If left untreated, patients with congenital adrenal hyperplasia due to 11β-hydroxylase deficiency may progress to develop [[malignant hypertension]].
If left untreated, patients with 11β-hydroxylase deficiency may progress to develop [[malignant hypertension|malignant hypertension.]]Untreated children progress into isosexual or contra-sexual pseudo-[[precocious puberty]]; early [[puberty]] in boys, [[acne]] and [[hirsutism]] in girls, [[menstrual irregularities]] in women, and [[infertility]] .<ref name="pmid6296182">{{cite journal |vauthors=Zachmann M, Tassinari D, Prader A |title=Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients |journal=J. Clin. Endocrinol. Metab. |volume=56 |issue=2 |pages=222–9 |year=1983 |pmid=6296182 |doi=10.1210/jcem-56-2-222 |url=}}</ref><ref name="pmid28576284">{{cite journal |vauthors=El-Maouche D, Arlt W, Merke DP |title=Congenital adrenal hyperplasia |journal=Lancet |volume= |issue= |pages= |year=2017 |pmid=28576284 |doi=10.1016/S0140-6736(17)31431-9 |url=}}</ref>
 
Untreated children progress into isosexual or contrasexual precocious pseudopuberty.<ref name="pmid6296182">{{cite journal |vauthors=Zachmann M, Tassinari D, Prader A |title=Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients |journal=J. Clin. Endocrinol. Metab. |volume=56 |issue=2 |pages=222–9 |year=1983 |pmid=6296182 |doi=10.1210/jcem-56-2-222 |url=}}</ref><ref name="pmid28576284">{{cite journal |vauthors=El-Maouche D, Arlt W, Merke DP |title=Congenital adrenal hyperplasia |journal=Lancet |volume= |issue= |pages= |year=2017 |pmid=28576284 |doi=10.1016/S0140-6736(17)31431-9 |url=}}</ref>


==Complications==
==Complications==
===Complications of Hypertension===
===Complications of Hypertension===
* Vascular hemorrhage
* [[Vascular]] [[hemorrhage]]
* [[Renal insufficiency]]
* [[Renal insufficiency]]
* [[Left ventricular hypertrophy]]
* [[Left ventricular hypertrophy]]
Line 17: Line 15:
* [[Stroke]]
* [[Stroke]]
===Complications of Hypokalemia===
===Complications of Hypokalemia===
* Muscle weakness
* [[Muscle weakness]]
* [[Metabolic alkalosis]]
* [[Metabolic alkalosis]]
* [[Paralytic ileus]]
* [[Paralytic ileus]]
===Other Complications===
===Other Complications===
* Early [[puberty]] in boys
* [[Acne]]
* [[Hirsutism]] in girls
* [[Menstrual irregularities]] in women
* [[Azoospermia]]
* [[Azoospermia]]
* [[Oligospermia]]
* [[Oligospermia]]
* [[Infertility]]
* [[Infertility]]
==Prognosis==
==Prognosis==
*The prognosis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency is generally good with treatment.<ref name="pmid6296182">{{cite journal |vauthors=Zachmann M, Tassinari D, Prader A |title=Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients |journal=J. Clin. Endocrinol. Metab. |volume=56 |issue=2 |pages=222–9 |year=1983 |pmid=6296182 |doi=10.1210/jcem-56-2-222 |url=}}</ref><ref name="pmid28576284">{{cite journal |vauthors=El-Maouche D, Arlt W, Merke DP |title=Congenital adrenal hyperplasia |journal=Lancet |volume= |issue= |pages= |year=2017 |pmid=28576284 |doi=10.1016/S0140-6736(17)31431-9 |url=}}</ref>
*The prognosis of congenital adrenal hyperplasia due to [[11β-hydroxylase]] deficiency is generally good with treatment.<ref name="pmid6296182">{{cite journal |vauthors=Zachmann M, Tassinari D, Prader A |title=Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients |journal=J. Clin. Endocrinol. Metab. |volume=56 |issue=2 |pages=222–9 |year=1983 |pmid=6296182 |doi=10.1210/jcem-56-2-222 |url=}}</ref><ref name="pmid28576284">{{cite journal |vauthors=El-Maouche D, Arlt W, Merke DP |title=Congenital adrenal hyperplasia |journal=Lancet |volume= |issue= |pages= |year=2017 |pmid=28576284 |doi=10.1016/S0140-6736(17)31431-9 |url=}}</ref>
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 19:37, 18 October 2017

Congenital adrenal hyperplasia main page

11β-hydroxylase deficiency Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 11β-hydroxylase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

11β-hydroxylase deficiency natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 11β-hydroxylase deficiency natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 11β-hydroxylase deficiency natural history, complications and prognosis

CDC on 11β-hydroxylase deficiency natural history, complications and prognosis

11β-hydroxylase deficiency natural history, complications and prognosis in the news

Blogs on 11β-hydroxylase deficiency natural history, complications and prognosis

Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency

Risk calculators and risk factors for 11β-hydroxylase deficiency natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

Overview

If left untreated, patients with 11β-hydroxylase deficiency may progress to develop malignant hypertension. Common complications of 11β-hydroxylase deficiency include muscle weakness, metabolic alkalosis, menstrual irregularities in women, acne, hirsutism, and infertility. Prognosis is generally good with treatment.

Natural History

If left untreated, patients with 11β-hydroxylase deficiency may progress to develop malignant hypertension.Untreated children progress into isosexual or contra-sexual pseudo-precocious puberty; early puberty in boys, acne and hirsutism in girls, menstrual irregularities in women, and infertility .[1][2]

Complications

Complications of Hypertension

Complications of Hypokalemia

Other Complications

Prognosis

  • The prognosis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency is generally good with treatment.[1][2]

References

  1. 1.0 1.1 Zachmann M, Tassinari D, Prader A (1983). "Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients". J. Clin. Endocrinol. Metab. 56 (2): 222–9. doi:10.1210/jcem-56-2-222. PMID 6296182.
  2. 2.0 2.1 El-Maouche D, Arlt W, Merke DP (2017). "Congenital adrenal hyperplasia". Lancet. doi:10.1016/S0140-6736(17)31431-9. PMID 28576284.